Document |
Document Title |
WO/2023/274887A1 |
The invention relates to bio-based isethionate compounds, their preparation, their uses, and formulations comprising the bio-based isethionate compounds.
|
WO/2023/278843A2 |
Provided herein are solid forms of osanetant, including salts thereof, processes for making the solid forms, and their therapeutic methods of use. Also provided is a process for preparing osanetant, and intermediates for use in the same.
|
WO/2022/271557A1 |
Provided herein are processes for the preparation of (S)-2-(2,6- dioxopipelidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-l
-yl) methyl) benzyl)amino)isoindoline-l, 3-dione, or a salt, solvate, hydrate, enantiomer, mixture of enantiome...
|
WO/2022/270230A1 |
Provided is an active-light-sensitive or radiation-sensitive resin composition that yields a pattern having exceptional cross-sectional rectangularity. This active-light-sensitive or radiation-sensitive resin composition contains: a resi...
|
WO/2022/268825A1 |
The disclosure relates to oral formulations for gastric delivery of a pharmaceutically acceptable salt of a phenyl pyrrole aminoguanidine compound.
|
WO/2022/262577A1 |
The present invention relates to a mesylate or ethanesulfonate salt of a compound as represented by formula (I), a preparation method therefor, a pharmaceutical composition comprising the salt, and an application of the salt.
|
WO/2022/265034A1 |
The resist composition comprises a resin component (A1) and a compound (B0) represented by general formula (b0) (In the formula, X0 is a bromine atom or iodine atom. Rm is a hydroxy group, etc. nb1 is 1 to 5, nb2 is 0 to 4, and 1 ≤ nb1...
|
WO/2022/261635A1 |
A surfactant composition includes a homogeneous mixture of greater than 70%, by weight, of N-acyl alaninate surfactant of formula (I) and an N-acyl amino acid surfactant of formula (II). A process for preparation of a blend of an N-acyl ...
|
WO/2022/256505A2 |
Provided herein are, inter alia, compounds of Formula (I): biomolecules (e.g., proteins, lipids, RNA, glycans) comprising the compounds; bioconjugates comprising the compounds; processes for preparing the compounds, biomolecules, and bio...
|
WO/2022/252404A1 |
Provided in the present invention are a fluorosulfonyl free radical reagent, and a preparation method therefor and the use thereof, belonging to the technical field of organic synthesis. The fluorosulfonyl free radical reagent provided b...
|
WO/2022/254047A1 |
The invention generally relates to emodin derivatives of general structure (I), to pharmaceutical compositions comprising same and to their uses in medicine, especially in the treatment of bacterial or viral infections. The invention fur...
|
WO/2022/253907A1 |
The invention provides a pharmaceutically acceptable salt of 5-[[5-[4-(4-fluoro-1-methyl-4-piperidyl)-2-methoxy-phenyl]-1
H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile which is selected from maleate, tosylate, besylate and malonate salts....
|
WO/2022/237904A1 |
A naphthalene ring-containing compound, a pharmaceutical composition containing same, and the use thereof. A naphthalene ring-containing compound as represented by formula III, a pharmaceutically acceptable salt thereof, a solvate thereo...
|
WO/2022/233282A1 |
Disclosed are a polysulfonic acid compound and an intermediate and an application thereof. The polysulfonic acid compound is as represented by formula I-1 or I-2 .Under the catalysis of the compound, the asymmetric hydrogenation alkoxy c...
|
WO/2022/232949A1 |
The present application includes a process for preparing the (R)- or (S)- enantiomers of 3,4-methylenedioxymethamphetamine ((R)-MDMA or (S)-MDMA) and (R)- or (S)-N-methyl-1,3-benzodioxolylbutanamine ((R)-MBDB or (S)-MBDB) using (R)- tert...
|
WO/2022/235906A1 |
Provided herein are solid forms of alpha-(aminomethyl)-4-(hydroxymethyl)-N-6-isoquinolinyl-(S)-
benzeneacetamide mono-tosylate salt ("Compound 1 mono-tosylate"), pharmaceutical compositions containing the solid forms, methods of produci...
|
WO/2022/229377A1 |
The present invention relates to new amphiphilic perfluorinated compounds and their use as a detergent for extracting membrane-proteins or synthesizing membrane-proteins in acellular system. It also relates to a method for extracting a m...
|
WO/2022/224835A1 |
Provided is a compound having a structure represented by general formula (A). (In formula (A), Ar is a C5-20 aromatic ring group constituting a ring, R31 represents a group represented by general formula (1), and R32 is a group represent...
|
WO/2022/225019A1 |
A resist composition containing a base component (A) and a compound (B0) represented by general formula (b0) wherein: Rb0 represents a fused ring group containing a fused ring containing one or more aromatic rings, said fused ring group ...
|
WO/2022/220201A1 |
The present invention provides: an active light-sensitive or radiation-sensitive resin composition which contains a compound represented by general formula (S1) and an acid-decomposable resin; a resist film which is formed using this act...
|
WO/2022/214054A1 |
Provided herein are a conjugate and the preparing method and use thereof. The conjugate of formula 1, M- [ (L1) a- (L2) b- (D) c] 1, wherein M is a biological macromolecule having a nucleophilic functional group, M is linked to L1 with t...
|
WO/2022/211812A1 |
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Human Respiratory Syncytial Virus (HRSV) or Human Metapneumovirus (HMPV) inhibitors. The present i...
|
WO/2022/211210A1 |
The present invention relates to a method for producing a fatty acid alkyl ester sulfonate by using a coffee-derived oil. The fatty acid alkyl ester sulfonate produced by using a coffee-derived oil of the present invention had excellent ...
|
WO/2022/201171A1 |
The present invention discloses polyethyleneamine salts of sulphonyl oleic acid and a 5 hydrocarbon fuel additive composition comprising the same. The said polyethyleneamine salts of sulphonyl oleic acid is made by mixing a sulphonyl ole...
|
WO/2022/198855A1 |
The present invention provides a system for efficiently preparing taurine. The system comprises: a liquid storage unit, configured to store a solution containing an alkali metal salt of taurine prepared by an ethylene oxide method; an io...
|
WO/2022/203074A1 |
Provided is a non-aqueous electrolyte containing a non-aqueous electrosolvent and a lithium salt, wherein the non-aqueous solvent includes a carbonate solvent, the lithium salt contains a fluorine-containing cyclic sulfonylimide salt rep...
|
WO/2022/202345A1 |
The present invention provides: an actinic-ray-sensitive or radiation-sensitive resin composition comprising (A) a resin which decomposes by the action of an acid to increase in polarity and (B) a compound which generates an acid upon ir...
|
WO/2022/202402A1 |
The present invention aims to provide: a production method for a semiconductor substrate that has excellent pattern rectangularity; and a composition for forming a resist underlayer film. The semiconductor substrate production method com...
|
WO/2022/195500A1 |
The present disclosure relates to a process for the preparation of lumateperone tosylate intermediate. The process comprises the conversion of benzyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-1,3,4,5-tetrahydro-2H
-pyrido[4,3-b]indole-2-car...
|
WO/2022/194566A1 |
The present invention relates to the purification of aliphatic taurate amides by liquid-liquid extraction, notably to remove free fatty carboxylic acids. Such aliphatic taurate amides may notably be obtained by reaction of a carboxylic a...
|
WO/2022/196001A1 |
Provided are: a radiation-sensitive resin composition which can be formed into a resist film having satisfactory levels of sensitivity and CDU performance even when a next-generation technology is applied; and a pattern formation method....
|
WO/2022/188758A1 |
The present invention relates to the field of biomedicine; provided are a quinoline compound salt or crystal form, a preparation method therefor, and an application thereof. The quinoline compound is as shown in formula (I), and the prov...
|
WO/2022/186264A1 |
The purpose of the present invention is to provide: a method for producing a fluorine-containing compound, the method using a readily available compound to produce a fluorine-containing compound under relatively mild reaction conditions;...
|
WO/2022/178594A1 |
The present disclosure relates to functionalized amino compounds that can provide inhibitors of C-reactive protein (CRP). The present disclosure also relates to pharmaceutical compositions containing such compounds, methods for using suc...
|
WO/2022/181695A1 |
The purpose of the present disclosure is to provide: a complex of a cell and a material; a method for producing a complex of a cell and a material; and a novel compound that can be used to obtain said complex. In a complex according to...
|
WO/2022/172602A1 |
The present invention addresses the problem of providing an actinic light-sensitive or radiation-sensitive resin composition that exhibits an excellent sensitivity to photoexposure. The present invention also addresses the problem of pro...
|
WO/2022/172685A1 |
Provided are a method for forming a resist pattern having excellent performance including sensitivity during a light exposure process, LWR performance and CDU performance even when a next-generation light exposure technology is applied t...
|
WO/2022/158442A1 |
The present invention provides, as a radioactive halogen-labeled precursor compound that is highly stable and reactive, a compound represented by general formula (II) [in the formula, R1 and R2 each independently represent an alkyl group...
|
WO/2022/149462A1 |
A light-absorbing material according to one embodiment of the present disclosure includes a compound represented by formula (1) as a main component. In formula (1): R1 to R30 are independent of each other and include at least one element...
|
WO/2022/149461A1 |
The nonlinear light absorption material according to one mode of the present disclosure contains, as a main component, a compound represented by formula (1). In formula (1), R1 to R15 each independently include at least one atom selected...
|
WO/2022/138603A1 |
A sulfonate composition production method comprising: reacting a diester (hereinafter, the (A) component) of a prescribed unsaturated carboxylic acid with (C) a sulfonating agent in the presence of (B) at least one solvent selected from ...
|
WO/2022/133544A1 |
Cannabidiol (CBD) cannabinoids and CBD cannabinoid analogues with, inter alia, antimicrobial activity, synthetic methods for the preparation thereof and medical uses and formulations containing same.
|
WO/2022/138602A1 |
The present invention is a sulfonate composition comprising, in predetermined mass ratios, (A) a compound represented by formula (1), (B) an organic solvent, (C) an inorganic metallic compound, and (D) water. (1): ROOC-(CH2)p-CH(SO3M)-CH...
|
WO/2022/138659A1 |
Provided is a method for producing a fluorovinyl ether compound capable of suppressing the generation of by-products. The method for producing a fluorovinyl ether compound of the present invention is a method for producing a fluoroviny...
|
WO/2022/129651A1 |
The present invention provides tyrosinase-inhibiting molecules of general formula (I) and a dermopharmaceutical or cosmetic composition that includes at least one of said tyrosinase-inhibiting molecules.
|
WO/2022/123575A1 |
The present invention pertains to present invention relates to a device comprising conjugate/s, and uses thereof in depleting at least one amine, specifically ammonia from body fluids. The present disclosure further provides systems, app...
|
WO/2022/116596A1 |
The invention relates to a concrete micro-foaming agent. The concrete micro-foaming agent contains the following components in parts by weight: 100-150 parts of a sulfonating agent, 0-100 parts of an alkaline agent, 100-200 parts of a un...
|
WO/2022/113814A1 |
Provided are: a radiation-sensitive resin composition able to exhibit satisfactory levels of sensitivity, LWR performance and CDU performance; a method for forming a pattern; and an onium salt compound. This radiation-sensitive resin com...
|
WO/2022/114138A1 |
Provided is a novel method for producing a (1R,2R,3R,5R,6R)-2-amino-6-fluoro-3-[(4-fluorophenyl)methoxy
]bicycle[3.1.0]hexane-2,6-dicarboxylic acid. This production method is characterized by relying on the conversion from a compound rep...
|
WO/2022/099826A1 |
The present invention relates to a Gemini polyoxyethylene ether succinate surfactant for oil displacement and a preparation method therefor. The present invention is characterized in that the surfactant is a Gemini alkylphenol polyoxyeth...
|